Drivers of Taiwan pharmaceutical market will include strong API sector, says Espicom report

22 February 2010

Taiwan is one of the richest countries in the Asia Pacific region. It has a strong health care system and the universal health insurance ensures that all citizens have grown to expect a high level of care, notes a new report from Espicom Business Intelligence. That said, like a lot of public welfare systems, the health care system is being constrained by rising costs, and a rapidly growing elderly population is adding to this.

In January 2009, the US Trade Representative removed Taiwan from its Special 301 Watch List of countries, attributing the move to the country's progress on protection and enforcement of intellectual property rights. It is a marked difference compared to when the USTR described the country as a haven for pirates in 2001, the year it was first placed on the list.

New FDA created to oversee pharma

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical